Skip to main content

Year: 2026

Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas

CINCINNATI, June 08, 2026 (GLOBE NEWSWIRE) — Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced it has acquired a formerly independent Roto-Rooter franchise serving 21 counties in south Texas for approximately $12.0 million. The service area includes the cities of Corpus Christi, McAllen, Laredo and Brownsville, Texas. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation’s largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services. Statements in this press release or in other Chemed communications may relate to future events or...

Continue reading

PetVivo Holdings, Inc. to Host Virtual Investor Event

Virtual investor event scheduled for Tuesday, June 16, 2026, at 1 p.m. ET MINNEAPOLIS, MN, US, June 08, 2026 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, announced today that it will host a virtual investor event titled “What Veterinarians Are Seeing and How Access Is Expanding” on Tuesday, June 16 at 1 p.m. ET. The event is designed for both new and current investors and will provide an overview of the Company’s business, including discussion around Spryng® with OsteoCushion® Technology, veterinary field feedback, and PetVivo’s ongoing efforts to expand access through sales and distribution relationships. The...

Continue reading

HII Partner Bayou Metals Launches Dedicated Manufacturing Line to Accelerate ROMULUS USV Production

SLIDELL, La., June 08, 2026 (GLOBE NEWSWIRE) — HII (NYSE: HII), America’s largest military shipbuilder and a global leader in autonomous maritime systems, today announced that Bayou Metal Supply & Manufacturing, a strategic partner in the serial production of HII’s ROMULUS unmanned surface vessels (USVs), has launched a dedicated manufacturing line to support accelerated construction of the platform. The new production line, located in Slidell, Louisiana, provides precision cutting, bending, welding, and assembly of major structural components into complete assembly units ready for shipment to Breaux Brothers Enterprises for final integration into the ROMULUS USV platform. Bayou Metals is playing a critical role on HII’s ROMULUS USV shipbuilding team as a strategic aluminum supply and fabrication partner. The company is providing...

Continue reading

Oliveda International, Inc. and Olive Tree People Inc. Subsidiary Prepare for Planned Nasdaq Listing

SANTA MONICA, CA, June 08, 2026 (GLOBE NEWSWIRE) — Oliveda International, Inc. (OTCID: OLVI) announced that today, on the day that its Olive Tree People Inc. subsidiary celebrates its third anniversary in North America, the two companies are officially preparing for a planned Nasdaq listing in 2027. Olive Tree People founder Thomas Lommel started in his Venice Beach garage in 2023 with a bold goal: to attract over 30,000 “waterless beauty consultants” within just 18 months to educate the public on waterless beauty, aiming to generate $5 million in revenue in the first year and over $100 million in the second. Eighteen months later, the company had not 30,000, but over 50,000 waterless beauty consultants. It generated $6.5 million in its first year and a sensational $104.5 million in annual revenue in its second, becoming...

Continue reading

Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference

Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant unmet medical needs, announced today that Oculis’ management will participate in a fireside chat at the 47th Annual Goldman Sachs Global Healthcare Conference.  The Company will provide an overview and update of its innovative current late-stage portfolio. Key highlights include: Privosegtor, a novel neuroprotective candidate which received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) and Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for optic neuritis (ON), in the PIONEER registrational program to address unmet needs for two optic neuropathies and to unlock a potential...

Continue reading

Toll Brothers Announces Grand Opening of Four New Model Homes at Outlook at The Station in Sunnyvale, California

New luxury condominiums in the heart of Silicon Valley with resort-style amenities SUNNYVALE, Calif., June 08, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the highly anticipated grand opening of four model homes at Outlook at The Station, a new community of luxury condominiums in Sunnyvale, California. The grand opening event will take place on Saturday, June 13, 2026 at 306 Tea Tree Terrace No. 3 in Sunnyvale. Home shoppers are invited to tour the beautifully designed Toll Brothers model homes and explore the community’s resort-style amenities. Outlook at The Station offers a collection of innovative condominium designs featuring 1 to 3 bedrooms, 974 to 1,955+ square feet, and 1 to 2 stories. The homes are thoughtfully designed with open-concept floor plans,...

Continue reading

AL Sydbank A/S share buyback programme: transactions in week 23

        Company Announcement No 29/2026Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37 AL Sydbank A/SCVR No DK 12626509, Aabenraaal-sydbank.com8 June 2026  Dear Sirs AL Sydbank A/S share buyback programme: transactions in week 23On 25 February 2026 AL Sydbank A/S announced a share buyback programme of DKK 1,100m. The share buyback programme commenced on 2 March 2026 and will be completed by 31 January 2027. The purpose of the share buyback programme is to reduce the share capital of AL Sydbank A/S and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under the...

Continue reading

Genco Shipping & Trading Limited Responds to Diana Shipping’s Withdrawal of Director Nominations

Diana’s Latest Actions Represent Last-Ditch Attempt to Gain Influence Over Genco’s Board and Acquire Genco on the Cheap Board Urges Shareholders to Vote FOR ALL of Genco’s Highly Qualified and Experienced Directors on the WHITE Proxy Card TODAY — and WITHHOLD on Diana’s Handpicked Nominees Additional Information Available at www.GencoDrivesSuperiorReturns.com NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today issued the following statement in response to the decision of Diana Shipping Inc. (“Diana”) to withdraw four of its director nominees for election to Genco’s Board. All three independent proxy advisory firms — ISS, Glass Lewis and Egan-Jones — recommended...

Continue reading

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

LITTLETON, Colo., June 08, 2026 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea (“OSA”), today announced that members of its executive management team will participate in The Small Cap Showcase & WTR Insights, taking place on June 9, 2026, in New York City. Representing the Company, Kirk Hunstman, CEO, will deliver a corporate presentation at 11:30 am ET and will participate in one-on-one meetings with pre-qualified investors throughout the day. The Small Cap Showcase & WTR Insights brings together executive management teams from approximately 20 micro and small-cap companies across a diverse...

Continue reading

Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, announces the completion of the first clinical cases performed using the next‑generation CORI◊ XT Handheld Robotics Platform, marking an important milestone in the clinical introduction of its latest handheld robotics technology. CORI XT Handheld Robotic Platform is designed to be the single handheld robotics platform for all orthopaedic needs – partial to revision knee, hip*, and anatomic and reverse shoulders – with a footprint tailored to the unique needs of hospitals and ambulatory surgical suites settings. These early cases represent the first use of CORI XT Platform across both knee and shoulder arthroplasty and reflect Smith+Nephew’s Skill Amplified approach to handheld robotics—designing technology to support and enhance surgeon expertise while...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.